The safety and effectiveness of Regeneron’s antibody treatment have not yet been proven. Regeneron announced Wednesday that it has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration for its COVID-19 antibody treatment. The company says that if the drug is approved, the government has committed to making the drug available to Americans at no cost. Trump has explicitly that he would like to make the drug available and free for everyone. Regeneron says they currently have doses of the drug available for about 50,000 patients and expect to have enough for 300,000 patients within the coming months.

DETROIT There has been an emphasis put on developing widespread coronavirus (COVID-19) antibody testing as we move forward through the pandemic. Local 4s Dr. Frank McGeorge explain exactly what antibodies are and why developing a test for them is so complicated. Luckily, there are other ways your immune system fights invaders until special antibody making cells can get to work. Aug. 6, 2020 -- Michigan coronavirus (COVID-19) cases up to 85,429; Death toll now at 6,247Eventually, after a few days of infection those antibody making cells are ready and start cranking out antibodies. The cells that made those antibodies also keep a record, so they can make antibodies faster the next time around.